Ever Source Wealth Advisors, LLC Compass Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 6,229 shares of CMPX stock, worth $25,912. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,229
Previous 21
29561.9%
Holding current value
$25,912
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CMPX
# of Institutions
105Shares Held
101MCall Options Held
18.2KPut Options Held
2.51M-
Orbimed Advisors LLC San Diego, CA15.2MShares$63.3 Million1.41% of portfolio
-
Tang Capital Management LLC San Diego, CA13.5MShares$56.1 Million2.1% of portfolio
-
Blackstone Inc New York, NY10MShares$41.7 Million0.12% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.15MShares$29.7 Million0.64% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$27.5 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $421M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...